ATHA
HEALTHYAthira Pharma, Inc.
CIK: 0001620463
Sell
(70% confidence)
Last activity: Jan 2, 2026
Financial Metrics
As of Dec 31, 2024 (10-K)
Net Income -$96.94M
Total Cash $93.42M
Insider Roster (5 total, 5 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Litton Mark James President and CEO | 0 | 1 | -$18K | 40,828 shares $281K |
| San Martin Javier CHIEF MEDICAL OFFICER | 0 | 1 | -$11K | 10,189 shares $70K |
| Worthington Mark General Counsel and CCO | 0 | 1 | -$6K | 13,978 shares $96K |
| CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 0 | 1 | -$6K | 20,681 shares $142K |
| Renninger Robert Chief Financial Officer | 0 | 1 | -$2K | 12,857 shares $88K |
Recent Transactions
SELL Litton Mark James (President and CEO)
2,586 shares @ $6.88
$18K
Jan 2, 2026
Conviction: |
View SEC Filing →
SELL San Martin Javier (CHIEF MEDICAL OFFICER)
1,644 shares @ $6.88
$11K
Jan 2, 2026
Conviction: |
View SEC Filing →
SELL Worthington Mark (General Counsel and CCO)
876 shares @ $6.88
$6K
Jan 2, 2026
Conviction: |
View SEC Filing →
SELL CHURCH KEVIN (CHIEF SCIENTIFIC OFFICER)
876 shares @ $6.88
$6K
Jan 2, 2026
Conviction: |
View SEC Filing →
SELL Renninger Robert (Chief Financial Officer)
297 shares @ $6.88
$2K
Jan 2, 2026
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.